Bryan Hedgpeth, Exxon Mobil Biomedical Sciences, Inc.

Bryan has been working within ExxonMobil Biomedical Sciences, Inc. (EMBSI) since 2014 in the toxicology and environmental sciences section. Bryan received his B.S. in marine biology from Central Methodist University. Following Central Methodist he attended the University of Southern Mississippi Gulf Coast Research Laboratory, where his research focused on aquatic toxicology in the marine environment. After graduating with his M.S. in aquatic toxicology, Bryan worked for the University Of Georgia College Of Veterinary Medicine, where he assisted with the development of antibiotics for fish aquaculture. He then worked for a Contract Research Organization in Kansas before joining EMBSI in 2014. After joining EMBSI he began his Ph.D. in molecular bioscience at Seton Hall University, which he completed in 2019. His Ph.D. research focused on fish embryo toxicity testing and usage of a passive sampling method (BE-SPME) to identify a sensitive exposure metric to reduce overall fish toxicity testing. Bryan is passionate about increasing the visibility of HDSETAC within the region as well as contributing to the scientific community by advocating for quality research.